Skip to content

Clinical trials

Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1/2 Country / region: Canada Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20101
20121
20152
20161
20182
20202
20212
20222
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated5
Recruiting4
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Alentis Therapeutics AG1
Bristol-Myers Squibb1
Cascadian Therapeutics Inc.1
Centre hospitalier de l'Université de Montréal (CHUM)1
Gilead Sciences1
GlaxoSmithKline1
Klus Pharma Inc.1
LigaChem Biosciences, Inc.1
Medicenna Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck18
Carcinoma, Non-Small-Cell Lung8
Uterine Cervical Neoplasms7
Triple Negative Breast Neoplasms6
Carcinoma, Renal Cell5
Head and Neck Neoplasms5
Melanoma5
Stomach Neoplasms5
Ovarian Neoplasms4
Carcinoma, Ovarian Epithelial3

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.